Matches in SemOpenAlex for { <https://semopenalex.org/work/W2342300503> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2342300503 endingPage "20" @default.
- W2342300503 startingPage "216" @default.
- W2342300503 abstract "Tumour necrosis factor-alpha (TNF-alpha) is regarded as one of the immune factors that can induce demyelination of peripheral nerves in patients with Guillian-Barre syndrome (GBS). This present study was undertaken to find out the role of TNF-alpha and soluble TNF receptors in the pathogenesis of GBS; and to study the effect of intravenous immunoglobulin (ivIg) therapy on the serum TNF-alpha and soluble TNF receptors in patients with GBS.Thirty six patients with GBS in progressive stages of motor weakness were included in this study. The serum TNF-alpha and soluble TNF receptors (TNF-RI, TNF-RII) were measured in the serum samples of these patients before and after ivIg therapy by a sandwich ELISA.Of the 36 patients with GBS, 26 (72.2%) showed elevated serum TNF-alpha levels prior to ivIg therapy. Following a complete course of ivIg therapy there was a progressive decrease in the serum TNF-alpha concentrations in these 26 patients. On the other hand, the soluble TNF receptors, particularly TNF-RII showed an increase in the serum of GBS patients following ivIg therapy.The results indicate that ivIg reduces the serum TNF-alpha concentrations in the GBS patients having elevated levels prior to ivIg therapy. Elevated serum levels of soluble TNF receptors following ivIg therapy may play a protective role by inhibiting the demyelinating effect of TNF-alpha in the peripheral nerves of patients with GBS." @default.
- W2342300503 created "2016-06-24" @default.
- W2342300503 creator A5009976564 @default.
- W2342300503 creator A5039441410 @default.
- W2342300503 creator A5071668660 @default.
- W2342300503 creator A5072729503 @default.
- W2342300503 creator A5074665788 @default.
- W2342300503 date "2003-05-01" @default.
- W2342300503 modified "2023-09-23" @default.
- W2342300503 title "Circulating tumour necrosis factor alpha & soluble TNF receptors in patients with Guillain-Barre syndrome." @default.
- W2342300503 cites W1552669957 @default.
- W2342300503 cites W1585076468 @default.
- W2342300503 cites W1977282646 @default.
- W2342300503 cites W2025392129 @default.
- W2342300503 cites W2033261949 @default.
- W2342300503 cites W2068103783 @default.
- W2342300503 cites W2084880911 @default.
- W2342300503 cites W2091179400 @default.
- W2342300503 cites W2094288436 @default.
- W2342300503 cites W2102572376 @default.
- W2342300503 cites W2163550872 @default.
- W2342300503 cites W2312313151 @default.
- W2342300503 cites W2398745476 @default.
- W2342300503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14609050" @default.
- W2342300503 hasPublicationYear "2003" @default.
- W2342300503 type Work @default.
- W2342300503 sameAs 2342300503 @default.
- W2342300503 citedByCount "4" @default.
- W2342300503 countsByYear W23423005032015 @default.
- W2342300503 countsByYear W23423005032018 @default.
- W2342300503 countsByYear W23423005032019 @default.
- W2342300503 crossrefType "journal-article" @default.
- W2342300503 hasAuthorship W2342300503A5009976564 @default.
- W2342300503 hasAuthorship W2342300503A5039441410 @default.
- W2342300503 hasAuthorship W2342300503A5071668660 @default.
- W2342300503 hasAuthorship W2342300503A5072729503 @default.
- W2342300503 hasAuthorship W2342300503A5074665788 @default.
- W2342300503 hasConcept C126322002 @default.
- W2342300503 hasConcept C134018914 @default.
- W2342300503 hasConcept C141071460 @default.
- W2342300503 hasConcept C159654299 @default.
- W2342300503 hasConcept C170493617 @default.
- W2342300503 hasConcept C17991360 @default.
- W2342300503 hasConcept C203014093 @default.
- W2342300503 hasConcept C2775944032 @default.
- W2342300503 hasConcept C2778691916 @default.
- W2342300503 hasConcept C2780942790 @default.
- W2342300503 hasConcept C46762472 @default.
- W2342300503 hasConcept C49453240 @default.
- W2342300503 hasConcept C64943373 @default.
- W2342300503 hasConcept C71924100 @default.
- W2342300503 hasConcept C90924648 @default.
- W2342300503 hasConceptScore W2342300503C126322002 @default.
- W2342300503 hasConceptScore W2342300503C134018914 @default.
- W2342300503 hasConceptScore W2342300503C141071460 @default.
- W2342300503 hasConceptScore W2342300503C159654299 @default.
- W2342300503 hasConceptScore W2342300503C170493617 @default.
- W2342300503 hasConceptScore W2342300503C17991360 @default.
- W2342300503 hasConceptScore W2342300503C203014093 @default.
- W2342300503 hasConceptScore W2342300503C2775944032 @default.
- W2342300503 hasConceptScore W2342300503C2778691916 @default.
- W2342300503 hasConceptScore W2342300503C2780942790 @default.
- W2342300503 hasConceptScore W2342300503C46762472 @default.
- W2342300503 hasConceptScore W2342300503C49453240 @default.
- W2342300503 hasConceptScore W2342300503C64943373 @default.
- W2342300503 hasConceptScore W2342300503C71924100 @default.
- W2342300503 hasConceptScore W2342300503C90924648 @default.
- W2342300503 hasLocation W23423005031 @default.
- W2342300503 hasOpenAccess W2342300503 @default.
- W2342300503 hasPrimaryLocation W23423005031 @default.
- W2342300503 hasRelatedWork W2018368842 @default.
- W2342300503 hasRelatedWork W2034583712 @default.
- W2342300503 hasRelatedWork W2057286656 @default.
- W2342300503 hasRelatedWork W2059084247 @default.
- W2342300503 hasRelatedWork W2063619316 @default.
- W2342300503 hasRelatedWork W2074821979 @default.
- W2342300503 hasRelatedWork W2101083005 @default.
- W2342300503 hasRelatedWork W2147147096 @default.
- W2342300503 hasRelatedWork W2169225653 @default.
- W2342300503 hasRelatedWork W2414846389 @default.
- W2342300503 hasVolume "117" @default.
- W2342300503 isParatext "false" @default.
- W2342300503 isRetracted "false" @default.
- W2342300503 magId "2342300503" @default.
- W2342300503 workType "article" @default.